Neutrolis
Cambridge, United States · Founded 2017 · $23.1M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- neutrolis.com
- Total Funding
- $23.1M
- Last Round
- $23.1M Series ADec 2021
- Rounds
- 1
About
Clinical-stage biotech developing first-in-class therapies targeting neutrophil extracellular traps for autoimmune and inflammatory diseases.
Summary
Neutrolis is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $23.1M in total across 1 round, most recently a $23.1M Series A round in Dec 2021. Investors include Morningside Group and Oceanpine Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2021
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.